Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Two MIT Professors Named Howard Hughes Medical Institute Investigators

Published: Friday, May 10, 2013
Last Updated: Friday, May 10, 2013
Bookmark and Share
Peter Reddien and Aviv Regev are among 27 top biomedical scientists selected nationwide.

Two members of the MIT faculty — Peter Reddien and Aviv Regev — have been named Howard Hughes Medical Institute (HHMI) investigators, bringing the total number of MIT professors who hold the distinction to 18.

Selected for their scientific excellence, HHMI investigators remain at their home institutions, but HHMI pays their salaries and funds much of their research. This gives the investigators freedom to explore, change direction in their research and see their ideas through to fruition — even if that process takes many years. Reddien and Regev will begin their five-year HHMI appointments in September.

“HHMI has a very simple mission,” HHMI President Robert Tjian said in announcing the new investigators. “We find the best original-thinking scientists and give them the resources to follow their instincts in discovering basic biological processes that may one day lead to better medical outcomes. This is a very talented group of scientists. And while we cannot predict where their research will take them, we’re eager to help them move science forward.”

Reddien and Regev were among 27 biomedical scientists selected as new HHMI investigators from 1,155 applicants. HHMI currently supports approximately 330 investigators throughout the country, including 15 Nobel laureates and more than 150 members of the National Academy of Sciences.

Peter Reddien

Peter Reddien is an associate professor of biology and associate head of MIT’s Department of Biology. He is also a member of the Whitehead Institute for Biomedical Research, an associate member of the Broad Institute and an HHMI Early Career Scientist.

Reddien’s work centers on the study of planaria, flatworms that have regenerative abilities. His lab seeks to identify and understand the molecular and cellular mechanisms that control these worms’ regeneration. His group discovered that planaria are equipped with stem cells that have the capacity to become any type of cell in their bodies — and that these cells create new tissue during regeneration.

Reddien continues to investigate the sources of planaria’s regenerative powers. His insights may lead to new understanding of the genes and pathways that control tissue repair and stem cells in humans. His work may also help reveal the limits of the human body to regenerate lost or injured tissue.

Aviv Regev


Aviv Regev is an associate professor of biology at MIT. She is also a core faculty member and director of the Klarman Cell Observatory at the Broad Institute and an HHMI Early Career Scientist.

Regev uses computational and experimental approaches to investigate how molecular networks that regulate gene activity respond to genetic and environmental changes — in the short term and over millennia. She has developed, among other things, techniques to analyze how yeast genes and regulatory networks have changed over 300 million years and how circuits change as immune cells respond to pathogens.

Additionally, her lab is using advanced experimental techniques, such as inserting genes into cells with silicon nanowires, to chart the molecular circuitry of T cells. Her algorithms are used in labs around the world to analyze gene expression data and other information.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Wednesday, April 27, 2016
Why Some Tumors Withstand Treatment
Mechanism uncovered that allows cancer cells to evade targeted therapies.
Thursday, March 17, 2016
Paving the Way for Metastasis
Cancer cells remodel their environment to make it easier to reach nearby blood vessels.
Tuesday, March 15, 2016
Mapping Regulatory Elements
Systematically searching DNA for regulatory elements indicates limits of previous thinking
Wednesday, February 03, 2016
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Friday, January 29, 2016
Supply Chain
Chemists discover how a single enzyme maintains a cell’s pool of DNA building blocks.
Wednesday, January 13, 2016
Tracing a Cellular Family Tree
New technique allows tracking of gene expression over generations of cells as they specialize.
Wednesday, January 06, 2016
New Device Uses Carbon Nanotubes to Snag Molecules
Nanotube “forest” in a microfluidic channel may help detect rare proteins and viruses.
Tuesday, December 22, 2015
Scaling Up Synthetic-Biology Innovation
MIT professor’s startup makes synthesizing genes many times more cost effective.
Monday, December 14, 2015
“Kill Switches” Shut Down Engineered Bacteria
Synthetic biology technique could make it safer to put engineered microbes to work outside of the lab.
Monday, December 14, 2015
Drug-Resistance Mechanism in Tumor Cells Unravelled
Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.
Friday, October 23, 2015
Learning About Human Health Using Sewage
PhD student Mariana Matus studies human waste to understand individual and community health.
Thursday, September 17, 2015
Real-Time Data for Cancer Therapy
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Thursday, August 06, 2015
Bacterial Computing
The “friendly” bacteria inside our digestive systems are being given an upgrade, which may one day allow them to be programmed to detect and ultimately treat diseases such as colon cancer and immune disorders.
Monday, July 13, 2015
Researchers Develop Genetic Tools to Engineer Common Gut Bacterium
Researchers from the Massachusetts Institute of Technology have developed genetic parts that can be combined to program the commensal gut bacterium Bacteroides thetaiotaomicron.
Friday, July 10, 2015
Scientific News
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Transcription Factor Isoforms Implicated in Colon Diseases
UC Riverside study explains how distribution of two forms of a transcription factor in the colon influence risk of disease.
Roundup Impacts Gene Expression
Study published on the impact of low-dose toxicity of Roundup weed-killer on gene expression profiles.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Triple-Negative Breast Cancer Target Is Found
Researchers at UC Berkeley discover a target that drives cancer metabolism in triple-negative breast cancer.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!